Lignospan Forte Injection, Solution
Product Images NDC 0362-1096

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Lignospan Forte (NDC 0362-1096). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Septodont, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

2928 4 Lignospan Forte Pc For Spl V3

Packaging label for Lignospan Forte injection, a submucosal solution containing Lidocaine Hydrochloride 2% (20 mg/mL) and Epinephrine 1:50,000. The label displays the brand and generic names, concentration, manufacturer (Septodont, Inc.), and packaging details indicating 50 single-dose cartridges of 1.7 mL each. It includes storage instructions and a barcode.*

FDA Label Image

Epinephrine

Chemical structure diagram showing the molecular composition of an active ingredient, featuring a benzene ring with two hydroxyl groups, a carbon atom, and an amine group. The structure corresponds to a component of Lidocaine Hydrochloride and Epinephrine injection.*

FDA Label Image

Lidocaine Hydrochloride

Chemical structure diagram of an active ingredient shown as a molecular formula with carbon (C), hydrogen (H), nitrogen (N), oxygen (O), and chlorine (Cl) atoms connected, consistent with lidocaine hydrochloride.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.